From the Food and Drug Administration.
Nightingale
S L
SL
D001067:Appetite Depressants / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004632:Emergency Medical Services; D005277:Fenfluramine / Q000009:adverse effects*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007258:Informed Consent; D010645:Phentermine / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing; D013792:Thalidomide; D014481:United States; D014486:United States Food and Drug Administration
D001067:Appetite Depressants; D017320:HIV Protease Inhibitors; D005277:Fenfluramine; D013792:Thalidomide; D010645:Phentermine